ask="7.20"
ask_size="700"
average_daily_volume="42118"
bid="4.99"
bid_size="1000"
book_value="5.08"
change="-0.16"
change_from_200_day_moving_average="-0.47"
change_from_50_day_moving_average="-0.11"
change_from_52_week_high="-7.58"
change_From_52_week_low="1.28"
change_in_percent="-3.00%"
close="5.17"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.06"
ebitda="-20.26M"
eps_estimate_current_year="-8.61"
eps_estimate_next_quarter="-0.80"
eps_estimate_next_year="-2.57"
ex_dividend_date="N/A"
float_shares="6404000"
high="5.35"
high_52_weeks="12.75"
last_trade_date="1/12/2017"
last_trade_price="5.17"
last_trade_size="100"
last_trade_time="3:59pm"
low="5.15"
low_52_weeks="3.89"
market_capitalization="69.43M"
moving_average_200_day="5.64"
moving_average_50_day="5.28"
name="Aeglea BioTherapeutics
Inc."
notes="N/A"
one_year_target_price="17.00"
open="5.29"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-8.26%"
percent_change_from_50_day_moving_average="-2.04%"
percent_change_from_52_week_high="-59.45%"
percent_change_from_52_week_low="+32.90%"
previous_close="5.33"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.05"
price_per_sales="14.41"
revenue="4.97M"
shares_outstanding="13430000"
short_ratio="0.21"
stock_exchange="NGM"
symbol="AGLE"
volume="2639"
weeks_range_52="3.89 - 12.75"
